NASDAQ:LYEL | Cash Flow Statement | Lyell Immunopharma, Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$44.76M
2026-03-31-$24.15M$2.33M-$38.51M$89,000.00$17.38M$51.72M
2025-12-31-$140.72M$2.4M-$32.25M$304,000.00-$31.37M$222,000.00
2025-09-30-$38.85M
2025-06-30-$42.68M
2025-03-31-$52.2M$3.44M-$54.74M$246,000.00$69.47M$1,000.00
2024-12-31-$191.94M$5.03M-$47.24M$44,000.00$53.51M$437,000.00
2024-09-30-$44.58M
2024-06-30-$45.81M
2024-03-31-$60.67M$5.02M-$42.02M$30,000.00$21.99M$27,000.00
2023-12-31-$52.93M$5.06M-$40.64M$25,000.00-$100.69M$759,000.00
2023-09-30-$50.85M
2023-06-30-$63.89M
2023-03-31-$66.96M$5.03M-$46.21M$1.53M$32.15M-$69,000.00
2022-12-31-$8.4M$5.04M-$40.27M$4.58M$46.65M$863,000.00
2022-09-30-$70.25M
2022-06-30-$36.32M
2022-03-31-$68.14M$4.19M-$47.85M$9.73M-$26.12M$2.56M
2021-12-31-$83.71M$4.57M-$33.21M$10.27M-$73.86M$7.4M
2021-09-30-$48.88M
2021-06-30-$62.6M
2021-03-31-$55.04M$1.96M-$33.6M$19.19M$136.68M$884,000.00
2020-12-31-$38.86M$1.45M-$26.73M$24.88M$32.39M$0.00$338,000.00
2020-09-30-$35.72M
2020-06-30-$100.66M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$274.45M$11.54M-$150.02M$780,000.00$54.1M$50.41M
2024-12-31-$342.99M$19.63M-$162.39M$464,000.00$122.42M$1.33M
2023-12-31-$234.63M$20.25M-$163.69M$2.69M$184.05M$1.74M
2022-12-31-$183.12M$18.02M-$169.56M$24.28M-$11.54M$0.00$10.64M
2021-12-31-$250.22M$13.62M-$126.25M$65.5M-$121.57M$0.00$401.24M
2020-12-31-$204.47M$4.29M-$160.87M$51.48M-$273.52M$11.81M$476.79M
2019-12-31-$129.38M$1.26M$39.47M$16.05M-$422.43M$185,000.00$351.16M